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ABSTRACT Most local anesthetics (LAs) elicit use-dependent inhibition of Na+ currents when excitable membranes are
stimulated repetitively. One exception to this rule is benzocaine, a neutral LA that fails to produce appreciable use-dependent
inhibition. In this study, we have examined the use-dependent phenomenon of three benzocaine homologs: ethyl 4-dieth-
ylaminobenzoate, ethyl 4-ethoxybenzoate, and ethyl 4-hydroxybenzoate. Ethyl 4-hydroxybenzoate at 1 mM, like benzocaine,
elicited little use-dependent inhibition of Na+ currents, whereas ethyl 4-diethylaminobenzoate at 0.15 mM and ethyl
4-ethoxybenzoate at 0.5 mM elicited substantial use-dependent inhibition-up to 55% of peak Na+ currents were inhibited
by repetitive depolarizations at 5 Hz. Each of these compounds produced significant tonic block of Na+ currents at rest and
shifted the steady-state inactivation curve (h,o) toward the hyperpolarizing direction. Kinetic analyses showed that the
decaying phase of Na+ currents during a depolarizing pulse was significantly accelerated by all drugs, thus suggesting that
these drugs also block the activated channel. The recovery time course for the use-dependent inhibition of Na+ currents was
relatively slow, with time constants of 6.8 and 4.4 s for ethyl 4-diethylaminobenzoate and ethyl 4-ethoxybenzoate, respec-
tively. We conclude that benzocaine and 4-hydroxybenzoate interact with the open and inactivated channels during repetitive
pulses, but during the interpulse the complex dissociates too fast to accumulate sufficient use-dependent block of Na+
currents. In contrast, ethyl 4-diethylaminobenzoate and ethyl 4-ethoxybenzoate dissociate slowly from their binding site and
consequently elicit significant use-dependent block. A common LA binding site suffices to explain the presence and absence
of use-dependent block by benzocaine homologs during repetitive pulses.
INTRODUCTION
Benzocaine is a neutral local anesthetic (LA) that blocks the
propagation of action potentials in excitable membranes.
The pKa value of benzocaine is 2.54, an indication that
benzocaine is not protonated at physiological conditions
(less than 0.01%). The interactions between benzocaine and
the voltage-gated Na+ channel have been extensively stud-
ied over the last two decades (for a review see Butterworth
and Strichartz, 1990). Benzocaine at moderate concentra-
tions (0.1 to 1 mM) inhibits both Na+ and gating currents
tonically. During repetitive depolarizations benzocaine elic-
its little use-dependent block of Na+ or gating currents
(Hille, 1977; Neumcke et al., 1981; Schneider and Dubois,
1986). In contrast, tertiary amine LAs and their quaternary
derivatives elicit tonic and use-dependent block when the
membrane is depolarized infrequently (<0.1 Hz) and repet-
itively (.1 Hz), respectively (Strichartz, 1973; Courtney,
1975; Hille, 1977; Cahalan and Almers, 1979). Because
quaternary LAs elicit use-dependent block of Na+ and
gating currents, it is suggested that the charged form of
tertiary amine LAs is necessary for such a block (e.g., see
Schwarz et al., 1977; but see Chernoff and Strichartz, 1989).
There are two hypotheses that can account for the use-
dependent block. 1) According to Hille's modulated receptor
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hypothesis (Hille, 1977), different states of the Na+ channel
may exhibit different affinities for LAs. LAs are proposed to
have higher affinities to open and inactivated states than to the
resting state. As a result, during repetitive depolarizations Na+
channels frequently enter their open and inactivated states,
which in turn interact more strongly with LAs than the resting
state. 2) According to the guarded receptor hypothesis (Starmer
et al., 1984), the binding affinity is constant for LAs in the Na+
channel, but the activation and/or inactivation gate may mod-
ulate the access of LAs to their binding site. Upon depolariza-
tion, conducting open channels with both gates open leave the
LA binding site unguarded and thus accessible to LAs,
whereas nonconducting closed channels with gate(s) in the
closed conformation act to restrict drug access and possibly to
trap charged LAs in LA-bound channels. Both of these hy-
potheses suggest that there is a common binding site for
tertiary amine LAs.
The purpose of this study is to examine why benzocaine
fails to elicit significant use-dependent block. Because the
structure of benzocaine is relatively simple, it may also be
possible to determine the structural basis that prevents it from
producing use-dependent block. What are the explanations for
the lack of use-dependent block of Na+ currents by benzo-
caine? First, benzocaine may occupy a binding site that is
distinct from the binding site for tertiary amine LAs (e.g.,
Huang and Ehrenstein, 1981). Second, the recovery time
course of benzocaine is fast (too fast to accumulate the use-
dependent block) and is comparable to the recovery time
course of fast Na+ inactivation (Hile, 1977; Yeh and Tanguy,
1985). As a result, upon dissociation neutral benzocaine simply
diffuses away through a hydrophobic pathway. One approach
to discerning these two alternatives is to use various benzo-
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caine homologs to probe the binding site of benzocaine. If the
lack of use-dependent block of benzocaine is due to its distinct
binding site from other tertiary amine LA binding sites, all
benzocaine homologs may exhibit little use-dependent block
ofNa+ currents. In this study, we have taken this approach and
determined the use-dependent characteristics of benzocaine
and its homologs, ethyl 4-diethylaminobenzoate, ethyl
4-ethoxybenzoate, and ethyl 4-hydroxybenzoate.
MATERIALS AND METHODS
Chemicals
Benzocaine was purchased from Sigma Chemical Co. (St. Louis, MO).
Ethyl 4-diethylaminobenzoate, ethyl 4-ethoxybenzoate, and ethyl 4-hy-
droxybenzoate were obtained from Pfaltz and Bauer, Inc. (Waterbury, CT).
The chemical structures of these homologs are shown as follows:
H2N Q C-O-C2H5
Benzocaine (Ethyl4-aminobenzoate)
0
(C2H5AN -O-C2H5
Ethyl 4-diethylaminobenzoate
FIGURE 1 Tonic inhibition of
Na+ currents by benzocaine and its
homologs. The tonic effects of ben-
zocaine (1 mM), ethyl 4-hydroxyben-
zoate (1 mM), ethyl 4-diethylamino-
benzoate (0.15 mM), and ethyl
4-ethoxybenzoate (0.5 mM) on Na+
currents were examined in GH3 cells
under reversed Na+ gradient. Tonic
block of Na+ currents with use of ben-
zocaine (A) and ethyl 4-hydroxybenzo-
ate (B) was achieved very quickly, af-
ter approximately 2 and 6 min,
respectively. (C) A duration of 11-25
min (mean = 17.6 + 1.1 min, n = 23)
is needed to achieve tonic block with
ethyl 4-diethylaminobenzoate. (D)
Tonic block of Na+ current with ethyl
4-ethoxybenzoate occurred 10.7 ± 2.1
min (n = 14) after drug administration.
The holding potential was set at -100
mV. Prepulse was set at -130 mV for
100 ms, followed by an interpulse of
-100 mV for 0.2 ms to reset the fast
activation gate, then a test pulse of +30
mV for 4 ms. Notice that at the drug
concentrations used, approximately
40-50% of the maximum current was
inhibited by the time tonic block was
achieved; tonic block for experiments
in A-D and other cells was 36.7 +
4.4% (n = 3), 45.6 + 4.6% (n = 5),
54.3 ± 4.2% (n = 20), and 51.9 +
4.6% (n = 13), respectively.
HO
-O-C2H5
Ethyl 4-hydroxybenzoate
C2H5O Q -O-C2H5
Ety 4-ethoxyberzoate
A Benzocaine (1 mM)
ControlX1.5'
2'
C Ethyl 4-diethylaminobenzoate
Each compound was dissolved in dimethyl sulfoxide (DMSO) at 100-200
mM stock concentration. Stock solutions were stored at 4°C. The final
concentration of DMSO was 51%. DMSO at 0.15, 0.25, 0.5, and 1% has
little effect on Na+ currents in GH3 cells (n = 3 at each concentration). All
other chemicals were reagent grade from commercial sources.
Cell culture and whole-cell voltage clamp
GH3 cells were maintained in Dulbecco's modified Eagle's medium sup-
plemented with 10% fetal bovine serum and I x glutamine (Gibco Labo-
ratories, Grand Island, NY). Cells were plated on 35-mm tissue culture
dishes (Falcon Plastics, Cockeysville, MD). Experiments were carried out
1-4 days after plating, with cell density -30-80% confluent.
The whole-cell variant of the patch clamp method (Hamill et al.,
1981) was used to measure Na+ currents in GH3 cells. The 35-mm
culture dish was rinsed and used as a recording chamber (containing
-0.5 ml solution), which was continuously perfused with the external
solution containing (mM): 150 choline Cl, 0.2 CdCl2, 2 CaCl2, and 10
HEPES adjusted to pH 7.4 with tetramethylammonium hydroxide.
Micropipettes were fabricated from borosilicate capillary tubing and
had a tip resistance of -1 Mfl when filled with an internal high-Na+
solution containing (mM): 100 NaF, 30 NaCl, 10 EGTA, and 10 HEPES
adjusted to pH 7.2 with CsOH. Under this reversed Na+ gradient
condition, outward INa is easily visible at all voltages and remains stable
up to 45- to 60-min recording time. At the whole-cell configuration,
cells were generally allowed to equilibrate with the pipette solution for
5-15 min before experiments.
Data acquisition and analysis
The recording system consisted of a List EPC-7 amplifier (Medical
Systems Corp., Greenvale, NY), a homemade leak subtractor, and an
B Ethyl 4-hydroxybenzoate (1 mM)
21
700 pi
(0.15 MM)
4A
0.4ms
D Ethyl 4-ethoxybenzoate (0.5 mM)
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FIGURE 2 The time course of ethyl 4-c
currents before and after ethyl 4-diethyla
measured at 30-s intervals by the pulse pro
peak currents were normalized and plotted
fitted with a 2-exponential equation. The
0.17 min, n = 7, with a component of X
('r2 = 8.5 + 1.9 min, with a component
IBM-AT computer interfaced by a 125-k
Solutions, Solon, OH). Creation of volt
tion, and analysis were performed with
ments, Foster City, CA). On some oc
currents were further subtracted by P/4z
This procedure was omitted whenever p
effect on binding interactions and be
maximal frequency one could apply.
pulses were applied to the cell no P/-4
current was measured at 10-s interval
inactivation (h) protocol. No significant differences were found with a
ethylaminobenzoate 20-s interval protocol. Series resistance and capacitance current were
compensated for by the List EPC-7 device; -50-80% of series resis-
tance was compensated for. Curve fitting was performed with the
Levenberg-Marquardt algorithm (Marquardt, 1963). Results are ex-
pressed as mean ± SE.
RESULTS
Tonic inhibition of Na+ current by benzocaine
and its homologs
Benzocaine and its three homologs, without exception, in-
hibited the peak amplitude of Na+ currents at moderate
10 15 20 concentrations. Benzocaine and ethyl 4-hydroxybenzoate at
1 mM acted rather rapidly: within 2-6 min after application,(min) current reduction reached its steady-state level (Fig. 1, A
and B). In comparison, ethyl 4-diethylaminobenzoate at
diethylaminobenzoate block. The 0.15 mM was a slow-acting drug (Fig. 1 C). The reduction
mi-nobenzoate at 0.15 mM were of the peak current appeared to be biphasic over a 20-minotocol as described in Fig. 1. The of thep ak curren a ppeaedt iphic ove a 20-mm
against time. The curve was best period: the fast phase, completed within 3-5 mi, followed
re is a fast phase (Tl = 0.79 + by a slower phase. It required about 20-30 min of drug
21.8 ± 2.8%) and a slow phase treatment to reach the steady-state inhibition (Fig. 2). Even
of 34.7 ± 1.5%). at 0.5 mM, the block by ethyl 4-diethylaminobezoate did
not reach completion within 10 min. Ethyl 4-ethoxybenzo-
ate was an intermediate-acting drug, requiring about 5-10
age clamp pulses, data acquisi- min to reach steady-state (Fig. 1 D). The potency of these
pClamp software (Axon Instru- drugs varied significantly in the following order: ethyl 4-
-casions, leak and capacitance diethylaminobenzoate > ethyl 4-ethoxybenzoate > ethyl
4 protocol (e.g., Figs. 1 and 5). 4-hydroxybenzoate > benzocaine. Unfortunately, because
)ossible because of its potential of the slow-acting nature of some of these drugs and the low
cause of its limitation on the ..
In particular, when repetitive solublity of benzocaine homologs, meanngful dose-re-
protocol was used. Peak Na+ sponse curves for accurate assessment of their potency
Is in steady-state Na+ channel through current measurements could not be obtained. At
FIGURE 3 Voltage dependence of
peak Na+ current inhibition by benzo-
caine homologs. A family of peak Na+
currents was recorded at 10-s intervals
with test pulses ranging from -70 to
+80 mV for 8 ms. Holding potentials
and prepulse potential were set as de-
scribed in Fig. 2. A complete set of
control traces was taken first, then a
second set of traces was taken after
tonic inhibition by one of the drugs was
achieved (A and B for ethyl 4-diethyl-
aminobenzoate (0.15 mM, n = 5) and
ethyl 4-ethoxybenzoate (0.5 mM; n =
6), respectively). The peak current am-
plitude at each voltage was normalized
with respect to the value at +80 mV
and plotted against voltages. The de-
gree of reduction of peak current with
ethyl 4-diethylaminobenzoate and
ethyl 4-ethoxybenzoate was normal-
ized by the control value and plotted
against membrane voltage (C and D,
respectively). There is little voltage-de-
pendent inhibition of peak current; the
slopes for C and D are 0.0008 and
0.0003, respectively.
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minimum, cells will require more than 80-min survival time
when four different dosages of ethyl 4-diethylaminobenzo-
ate are applied.
Like benzocaine (Neumcke et al., 1981), none of its
homologs produced a voltage-dependent inhibition of the
peak current. Fig. 3, A and B, shows the current families
before and after 10- to 20-min treatment with ethyl 4-dieth-
ylaminobenzoate and ethyl 4-ethoxybenzoate, respectively.
The degree of reduction of peak currents at various voltages
was relatively constant for these drugs (Fig. 3, C and D).
Shifts in steady-state inactivation of Na+
channels by benzocaine homologs
Benzocaine significantly shifted the steady-state inactiva-
tion (hoo) of Na+ channels to the hyperpolarizing direction
by more than 20 mV in GH3 cells (Wang and Wang, 1994a).
A similar degree of shift has been found in other prepara-
tions (e.g., Hille, 1977). Like benzocaine, all benzocaine
homologs also shifted the h0,, curve in the hyperpolarizing
direction. Fig. 4, A and B, shows the steady-state inactiva-
tion curve measured by a conventional two-pulse protocol
(Hodgkin and Huxley, 1952; Meeder and Ulbricht, 1987)
for ethyl 4-diethylaminobenzoate and ethyl 4-ethoxybenzo-
ate, respectively. Inactivation curves were fitted with the
empirical Boltzmann equation, h0. = 1/[1 + exp (E -
Eo5)/k], where E is the prepulse potential, E0.5 is the poten-
tial for which h0. = 0.5, and k is a slope factor. These
parameters for benzocaine and its homologs are listed in
Table 1. To use this equation, we assumed that inactivation
reached steady state during the 50-ms prepulse duration.
This assumption is difficult to verify because a longer
prepulse duration will elicit slow inactivation of Na+ chan-
nels in GH3 cells.
Acceleration of the Na+ current decaying phase
by benzocaine homologs
Although there is no voltage-dependent inhibition of peak Na+
current amplitude as in Na+ current family measurement (Fig.
3), we noticed that the apparent rate of the Na+ current decay-
ing phase was consistently accelerated by benzocaine ho-
mologs at all voltages. The decay of the Na+ current at each
voltage could be well fitted by a single exponential term (T in
milliseconds) as described earlier (Cota and Armstrong, 1989).
Fig. 5, A and B, shows the current traces before and after ethyl
4-diethylaminobenzoate and before and after ethyl 4-ethoxy-
benzoate treatment, respectively. The 1/ values were plotted
against each voltage (Fig. 5, C and D). Significant acceleration
of Na+ current inactivation was found for both drugs. Similar
results were found for benzocaine and ethyl 4-hydroxybenzo-
ate (data not shown). Thus, benzocaine and its homologs
accelerate the apparent inactivation kinetics of Na+ currents in
GH3 cells. This finding is consistent with previous reports that
benzocaine speeds up the decaying phase of Na+ currents in
frog node of Ranvier (Neumcke et al., 1981; Schneider and
A
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FIGURE 4 Steady-state Na+ channel inactivation (h ) of ethyl 4-dieth-
ylaminobenzoate (0.15 mM) and ethyl 4-ethoxybenzoate (0.5 mM). Peak
Na+ current was measured at 10-s intervals with 50-ms prepulse voltages
(Epp) ranging from -150 to -20 mV. Holding potential was set at -100
mV, an interpulse was set at -100 mV for 0.08 ms to reset the activation
gate, and the test pulse was set at +50 mV for 3.6 ms. First, a complete set
of control traces was recorded, then a second set was taken after tonic
inhibition was achieved with one of the benzocaine homologs. Each family
of peak amplitudes was normalized with respect to the value at -150 mV
prepulse voltage. Each curve was then fitted using the Boltzmann equation,
y = 1/{ 1 + exp [(Epp- EO5)/k]), where k is the slope factor and E0o5 is
the voltage where 50% of Na+ channels were inactivated. In A, the ho5
value shifted from -73.3 ± 0.21 to -91.7 ± 0.42 mV, and k increased
from 8.6 ± 0.18 to 10.9 ± 0.37 mV using ethyl 4-diethylaminobenzocate
(n = 7). In B, ho5 shifted from -70.0 ± 0.16 to -98.9 ± 0.68 mV and k
increased from 9.0 ± 0.14 to 14.1 ± 0.60 mV using ethyl 4-ethoxyben-
zoate (n = 8). The shifts of the fitted ho.5 and the ratio of k values are listed
in Table 1.
DuBois, 1986). Because of their relatively fast kinetics, it is not
clear whether the rising phases of Na+ currents are signifi-
cantly altered by these drugs.
Use-dependent inhibition of Na+ currents by
benzocaine homologs
It is well established that benzocaine elicits little use-
dependent block when the membrane is repetitively depo-
larized at frequencies up to 5 Hz. In GH3 cells a similar
result was found, as shown in Fig. 6, B and C, for benzo-
caine and ethyl 4-hydroxybenzoate, respectively. In the
absence of these drugs, -20% of Na+ currents were inhib-
ited after 60 repetitive pulses of + 30 mV for 24 ms at 5 Hz
(Fig. 6 A). This reduction is probably due to a small fraction
197Quan et al.
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TABLE 1 Shifts in Na+ channel steady-state inactivation by
benzocaine homologs in GH3 cells
Concentration
Compounds (mM) AhO5 (mV) kdglontrol
Benzocaine* 1.0 -19.8 (n = 4) 1.10
Ethyl 4-diethylaminobenzoate 0.15 -18.4 (n = 7) 1.27
Ethyl 4-hydroxybenzoate 1.0 -25.9 (n = 4) 1.52
Ethyl 4-ethoxybenzoate 0.5 -28.9 (n = 8) 1.56
Parameters of ho.5 and k were first determined as described in Fig. 4. The
shift in steady-state inactivation (Aho.5) is the difference in ho.5 before and
after drug treatment. ho.5 is the midpoint of the inactivation curve.
*The data for benzocaine are taken from Wang and Wang (1994a).
of inactivated channels unable to recover during the 176-ms
interpulse duration. Lesser use-dependent block was found
at frequencies of 1 and 2 Hz (Fig. 6 A).
In contrast, both ethyl 4-diethylaminobenzoate and
ethyl 4-ethoxybenzoate elicited significant use-depen-
dent block during repetitive pulses at all three frequen-
cies. The peak current amplitude at each pulse was mea-
sured, normalized with respect to the value of the first
pulse, and plotted against the pulse number (Fig. 7, A and
C). The current traces in Fig. 7, B and D, show that up to
50-60% of Na+ currents are blocked after 60 pulses at 5
Hz by these two compounds. This result demonstrates
that alkylation of the 4-amino or 4-hydroxy functional
group in benzocaine homologs alters their use-dependent
characteristics.
Besides the frequency of the pulse, the duration of the
depolarization may also affect the degree of the use-
FIGURE 5 The effect of benzocaine A
homologs on the inactivation kinetics of \j<Control
Na+ currents in GH3 cells. A and B
show typical peak Na+ current traces
taken before drug application and after
achievement of tonic inhibition with Ethyl 4-die
ethyl 4-diethylaminobenzoate (0.15 0.15 rnM
mM) and ethyl 4-ethoxybenzoate (0.5
mM), respectively. The decay of each
current was fitted with a single expo-
nential equation. The T value decreased
from 0.43 to 0.28 ms after treatment
with ethyl 4-diethylaminobenzoate.
Similarly, T decreased from 0.35 to 0.24
ms after treatment with ethyl 4-ethoxy- C
benzoate. The R values for the T fittings 5 Ethyl 4-diethylaminob
were better than 0.998 (thin fitting lines 0.15 rM
in A and B). The single-exponential 4
equation was used to obtain T for each
membrane potential of each family as 3
shown in Fig. 3, A and B. The mean
inverse of T values was then plotted 2-
against voltage. At all voltages, both Contr
ethyl 4-diethylaminobenzoate and ethyl 1
4-ethoxybenzoate significantly increase 0
the inactivation kinetics of Na+ current -20 0 20 4
(C and D, respectively). Membrane volt
dependent block. Fig. 8, A and B, shows that this is the
case for ethyl 4-diethylaminobenzoate and ethyl
4-ethoxybenzoate. Reducing the duration from 24 ms to
10, 5, and 1 ms progressively decreased the level of the
use-dependent block elicited during repetitive pulses.
Because fast inactivation appears to complete within 5
ms (Fig. 1), this result indicates that binding of these
compounds continues long after the Na+ channels have
been inactivated. Furthermore, the steady-state level of
the use-dependent block could be reached only after
30-60 pulses, which suggests that during each pulse, the
additional binding of these benzocaine homologs is
small.
Recovery from the use-dependent inhibition of
Na+ currents
The recovery of Na+ currents from the use-dependent
block was measured by a test pulse with variable dura-
tions of rest at the holding potential of -100 mV after 30
repetitive pulses. Na+ currents recovered from the use-
dependent block with a single exponential time course of
about 6.8 and 4.1 s for ethyl 4-diethylaminobenzoate and
ethyl 4-ethoxybenzoate, respectively (Fig. 9). This slow
recovery from block is consistent with the observed use-
dependent block during repetitive pulses (Fig. 8), be-
cause the interpulse is too short (less than 0.5 s) to allow
a significant amount of current to recover at the holding
potential.
B
Ethyl 4-ethoxybenzoate
0.5 mM
0.6 nA[_
0.4 ms
D
40 60 80
tage (mV)
0 20 40 60 80
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FIGURE 6 Lack of use-dependent block of Na+ currents before and
after benzocaine (1.0 mM) or ethyl 4-hydroxybenzoate (1 mM). Holding
potential was set at -100 mV and repetitive pulses were set at + 30 mV for
24 ms at 1 to 5 Hz (see inset for pulse protocol). After the control sets of
peak amplitudes were recorded at 1, 2, and 5 Hz, the second sets were taken
after tonic inhibition was achieved with drug treatment. The peak ampli-
tude of each data set was normalized with respect to the amplitude of the
first pulse of its set. The peak amplitudes were then plotted against pulse
number. Under the control conditions in A there is 20.6 ± 1.3% use-
dependent inhibition of Na+ current at 5 Hz (n = 4) (0). The degree of
use-dependent inhibition, which was related to the applied frequency, was
13.3 ± 1.3% at 2 Hz (n = 15) (A) and 9.3 ± 1.3% at 1 Hz (n = 14) (O).
Treatment with benzocaine (B) elicited even less use-dependent inhibition
in Na+ current than the control. There were 3.8 ± 1.6% and 4.4 ± 1.4%
use-dependent block, respectively, at 1 Hz (n = 3) (E1) and 2 Hz (n = 3)
(A) and 9.8 ± 3% use dependence at 5 Hz (n = 3) (0). Treatment with
ethyl 4-hydroxybenzoate (C) similarly produced little use-dependent inhi-
bition: about 5% at both 1 (n = 6) and at 2 Hz (n = 6). At 5 Hz (n = 7)
there was a 17% reduction in peak amplitude; this value is comparable,
however, to that of the control at 5 Hz.
DISCUSSION
Use-dependent inhibition of Na+ currents by
benzocaine homologs
The main purpose of this study is to address whether
benzocaine homologs can elicit use-dependent block of
Na+ currents. Although numerous other benzocaine ho-
mologs have been examined, none of them appears to
produce use-dependent block (e.g., Elliott et al., 1987).
Our results clearly show that ethyl 4-diethylaminobenzo-
ate and ethyl 4-ethoxybenzoate produce use-dependent
block of Na+ currents, whereas benzocaine and ethyl
4-hydroxybenzoate do not. In a previous report (Wang
and Wang, 1994b), it was briefly stated that 1 mM ethyl
4-dimethylaminobenzoate can also produce significant
use-dependent block (up to 50% at 5 Hz). Together, these
data demonstrate that there are two types of benzocaine
homologs; only one type can elicit use-dependent block.
Thus, the lack of use-dependent block of Na+ currents by
benzocaine and ethyl 4-hydroxybenzoate cannot be used
as evidence for the existence of a separate neutral LA
binding site apart from the tertiary amine LA binding site
(for a review of this possibility see Butterworth and
Strichartz, 1990). Our results are consistent with the
notion that there is a common LA receptor responsible
for eliciting the use-dependent block upon binding, as
suggested by Hille (1977). Both ethyl 4-diethylamino-
benzoate and ethyl 4-ethoxybenzoate probably interact
more strongly with the open and inactivated Na+ chan-
nels than with the resting channels for the following
reasons. First, these compounds shift the steady-state
inactivation curve in the hyperpolarizing direction (Table
1). Such a shift is generally taken as evidence that LAs
bind preferentially with the inactivated channel (Hille,
1977; Bean et al., 1983; Meeder and Ulbricht, 1987).
Second, they accelerate the decaying phase of the Na+
current (Fig. 5). Third, they require a long duration, up
to 30 ms, of repetitive pulse to elicit maximal use-
dependent block (Fig. 8).
Structural determinant of benzocaine homologs
for use-dependent block
By examining the chemical structures of benzocaine homologs
it becomes apparent that alkylation of the 4-amino or 4-
hydroxy position of the phenyl ring will enable the homologs
to elicit use-dependent block as well as to increase tonic block.
Alkylation of these functional groups on the phenyl ring in-
creases the hydrophobicity and the molecular weight of the
compound. We have demonstrated previously in Na+ channels
that the binding site of tertiary amine LAs and quaternary
ammonium compounds consists of at least two large hydro-
phobic binding domains (Wang et al., 1993), each of which
may accommodate up to 12 carbons of an alkyl chain. Assum-
ing that there is a common receptor for all LAs, these alkylated
compounds, therefore, can easily be accepted by such hydro-
phobic binding domains.
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FIGURE 7 Use-dependent inhibi-
don of Na+ current elicited by ethyl
4-diethylaminobenzoate (0.15 mM)
and ethyl 4-ethoxybenzoate (0.5
mM). Using the same pulse proto-
cols, method of measuring, and nor-
malizing peak Na+ currents as de-
scribed in Fig. 6, we found that ethyl
4-diethylaminobenzoate (A) at 1 Hz
produced a 24.4 ± 5.9% (El) reduc-
tion in peak amplitude, whereas at 2
Hz (A) and 5 Hz (0) peak amplitudes
were reduced by 33.8 + 6.1% and
47.4% + 6.6 (n = 5), respectively.
Ethyl 4-ethoxybenzoate (C) evoked
about 5% greater use-dependent inhi-
bition than ethyl 4-diethylaminoben-
zoate. At 1, 2, and 5 Hz, there was a
28.8 ± 4.1%, 37.6 ± 4.3%, and 52.2
+ 5.3% (n = 5) reduction, respec-
tively. B and D show the representa-
tive Na+ current traces after repeti-
tive pulsing at 5 Hz in the presence of
ethyl 4-diethylaminobenzoate and
ethyl 4-ethoxybenzoate, respectively.
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FIGURE 8 The effect of pulse duration on the use-dependent block of peak
Na+ current. Repetitive test pulses were applied at +30 mV, between 1 and 24
ms, at 5 Hz. Holding potential was set at -100 mV. Measurements were
recorded when the cells had reached either steady state (as in the case of the
controls) or tonic inhibition (as in the case when a drug was administered).
Normalized peak current amplitude was plotted against pulse number. It is
evident that increasing the duration of the test pulse increases the amount of
inhibition of peak amplitude. (A) At a pulse duration of 1 ([), 5 (A), 10 (C>),
and 24 ms (0), ethyl 4-diethylaminoenzoate (0.15 mM) evoked 19.6 1.3%
(n = 6), 35.1 ± 1.6% (n = 6), 43.3 + 1.8% (n = 6), and 47.4 ± 6.6% (n =
6) inhibition of peak amplitude, respectively. (B) Similarly, ethyl 4-ethoxy-
benzoate (0.5 mM) produced 16.7 ± 1.9% (n = 6), 27.9 ± 3.6% (n = 6), 35.7
± 4.0% (n = 6), and 52.2 ± 5.3% (n = 5) inhibition at those durations,
respectively. In the absence of drugs, repetitive pulses of 1-, 5-, 10-, and 24-ms
duration elicited blocks of 4.8 ± 0.8%, 7.7 ± 0.9%, 9.6 ± 1.0%, and 19.7
1.7%, respectively; the degree of block is far less than that with drugs.
How does alkylation of benzocaine and ethyl 4-hydroxy-
benzoate enable these compounds to elicit use-dependent
block of Na+ currents? Apparently, alkylation slows the
recovery time course of benzocaine homologs (Fig. 9).
According to Hille (1977) the lack of use-dependent block
of Na+ currents by benzocaine is caused by relatively fast
dissociation of benzocaine from its receptor during inter-
pulses and by the quick diffusion of benzocaine in its
neutral form away from the pore region through the hydro-
phobic pathway. According to this same argument, there are
two conceivable ways to produce use-dependent block with
benzocaine homologs: first, slower dissociation of the al-
kylated benzocaine homologs from their receptor, and sec-
ond, slower diffusion of the alkylated homologs away from
the pore region through the hydrophobic pathway when the
hydrophilic pathway is closed by activation and/or inacti-
vation gate. The first possibility is likely because of the
potential increased hydrophobic interactions for the al-
kylated homologs. For the second possibility, it is not clear
how fast the benzocaine homologs can diffuse away from
the pore when the channel is closed. The increase in the
cylindric dimension of alkylated homologs is minimal, al-
though they do increase the length of the compounds. This
steric factor could reduce the diffusion rate of alkylated
benzocaine homologs from the pore when the channel is
closed. All of these compounds remain neutral and do not
carry charges under physiological conditions. Although
N,N-diethylaniline has a pKa 2 units higher than that of
aniline, the equivalent increase of ethyl 4-diethylaminoben-
zoate will still have a pKa of 4.5, or less than 1% in its
charged form at our experimental conditions. Our results are
in agreement, however, with the conclusion of Chernoff and
Strichartz (1989) that neither the presence of a tertiary
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FIGURE 9 Recovery of Na+ current from use-dependent block. A test
pulse of +30 mV for 8 ms was given at various intervals after each train
of 20 conditioning pulses of +30 mV for 30 ms at 5 Hz (see inset). Each
set of peak Na+ current amplitudes was measured after cells had achieved
tonic inhibition. The mean peak Na+ current amplitudes were normalized
with the amplitude at 90 s and then plotted against time. A and B show the
recovery of Na+ current from use-dependent inhibition with treatment of
ethyl 4-diethylaminobenzoate and ethyl 4-ethoxybenzoate, T = 6.8 ± 0.7
s (n = 6) and 4.1 ± 0.6 s (n = 4), respectively.
amine nor a net charge on the LA is required for use-
dependent block of Na+ channels.
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